The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survival with IDH wildtype glioblastoma: First results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
 
Michael Weller
Honoraria - Bayer; Novocure
Consulting or Advisory Role - Bayer (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Novartis; Orbus Therapeutics; Philogen; Pierre Fabre (I); Roche; Sandoz; Seagen (I)
Research Funding - Quercegen Pharmaceuticals (Inst); Versameb (Inst)
 
Joerg Felsberg
No Relationships to Disclose
 
Dorothee Gramatzki
No Relationships to Disclose
 
Emilie Le Rhun
Honoraria - Bayer (I); Novocure (I); Pierre Fabre
Consulting or Advisory Role - Bayer; CureVac (I); Janssen; Leo Pharma; Medac (I); Novartis (I); Orbus Therapeutics (I); Philogen (I); Roche (I); Sandoz (I); Seagen
Research Funding - Bristol-Myers Squibb (Inst)
 
Jennifer Leigh Clarke
Consulting or Advisory Role - Agios (Inst); SERVIER (Inst)
Research Funding - Agios (Inst); Merck (Inst); SERVIER (Inst)
 
Riccardo Soffietti
Consulting or Advisory Role - AstraZeneca; Bayer
 
Wolfgang Wick
Consulting or Advisory Role - Apogenix (Inst); AstraZeneca (Inst); Bayer (Inst); Enterome (Inst); Medac (Inst); MSD (Inst); Roche/Genentech (Inst)
 
Olivier L. Chinot
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
 
Francois Ducray
No Relationships to Disclose
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Midatech Pharma; MSD; QED Therapeutics
Research Funding - MSD (Inst); Novocure (Inst)
 
Peter Hau
Consulting or Advisory Role - Bayer; Lilly O.; Medac; Novartis; Novocure; Seagen
 
Martin Klein
No Relationships to Disclose
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche
 
Martin Bendszus
No Relationships to Disclose
 
Vassilis Golfinopoulos
No Relationships to Disclose
 
Andreas von Deimling
No Relationships to Disclose
 
Thierry Gorlia
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Genenta Science; GlaxoSmithKline; Insightec; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Novocure; Nuvation Bio; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; Vascular Biogenics; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Guido Reifenberger
No Relationships to Disclose
 
Caroline Hertler
Honoraria - Vifor Pharma
Research Funding - Filling the Gap